IDEXX Laboratories (NASDAQ: IDXX) net income
IDEXX Laboratories reported a net profit of $1,059m for fiscal 2025, 19.3% more than in fiscal 2024 ($887.9m). Its net margin was 24.6%. Earnings per share were $13.17.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $1,059m | +19.3% | 24.6% | $13.17 |
| 2024 | $887.9m | +5.1% | 22.8% | $10.77 |
| 2023 | $845.0m | +24.4% | 23.1% | $10.17 |
| 2022 | $679.1m | −8.8% | 20.2% | $8.12 |
| 2021 | $744.8m | +28.0% | 23.2% | $8.74 |
| 2020 | $581.8m | +36.0% | 21.5% | $6.82 |
| 2019 | $427.7m | +13.4% | 17.8% | $4.97 |
| 2018 | $377.0m | +43.3% | 17.0% | $4.34 |
| 2017 | $263.1m | +18.5% | 13.4% | $3.00 |
| 2016 | $222.0m | — | 12.5% | $2.47 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of IDEXX Laboratories
- How much did IDEXX Laboratories earn in fiscal 2025?
- IDEXX Laboratories reported a net profit of $1,059m for fiscal 2025. In fiscal 2024 it reported a net profit of $887.9m.
- What are the earnings per share of IDEXX Laboratories?
- They were $13.17 in fiscal 2025, compared with $10.77 in fiscal 2024.
- What is the net margin of IDEXX Laboratories?
- In fiscal 2025 its net profit was 24.6% of its revenue.
- What was the most profitable year for IDEXX Laboratories?
- Of its last 10 fiscal years, fiscal 2025, with $1,059m.
- Where do the figures for IDEXX Laboratories come from?
- From the annual report (Form 10-K) that IDEXX Laboratories files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that IDEXX Laboratories files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on IDEXX Laboratories: the IDEXX Laboratories page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.